The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

被引:2047
|
作者
Choe, H
Farzan, M
Sun, Y
Sullivan, N
Rollins, B
Ponath, PD
Wu, LJ
Mackay, CR
LaRosa, G
Newman, W
Gerard, N
Gerard, C
Sodroski, J
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
[2] LEUKOSITE INC,CAMBRIDGE,MA 02142
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,PERLMUTTER LAB,DEPT PEDIAT,DEPT MED,CHILDRENS HOSP,BOSTON,MA 02115
关键词
D O I
10.1016/S0092-8674(00)81313-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the ability of chemokine receptors and related G protein-coupled receptors to facilitate infection by primary, clinical HIV-1 isolates. CCR5, when expressed along with CD4, the HIV-1 receptor, allowed cell lines resistant to most primary HIV-1 isolates to be infected. CCR3 facilitated infection by a more restricted subset of primary viruses, and binding of the CCR3 ligand, eotaxin, inhibited infection by these isolates. Utilization of CCR3 and CCR5 on the target cell depended upon the sequence of the third variable (V3) region of the HIV-1 gp120 exterior envelope glycoprotein. The ability of various members of the chemokine receptor family to support the early stages of HIV-1 infection helps to explain viral tropism and beta-chemokine inhibition of primary HIV-1 isolates.
引用
收藏
页码:1135 / 1148
页数:14
相关论文
共 50 条
  • [41] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [42] Primary HIV isolates that are dual-tropic for the chemokine receptors ccR5 and cxcR4 (fusin, lestr).
    Blatner, G
    Blair, P
    June, C
    Cohen, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 53 - 53
  • [43] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [44] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    [J]. AIDS, 2008, 22 (16) : 2212 - 2214
  • [45] Expression and function of CCL5 and the receptors GPR75, CCR1, CCR3 and CCR5 in islets of Langerhans
    Hassan, Z.
    Liu, B.
    Amisten, S.
    Huang, G. C.
    Amiel, S. A.
    Jones, P. M.
    Persaud, S. J.
    [J]. DIABETOLOGIA, 2012, 55 : S164 - S164
  • [46] Human chemokine receptors CCR5, CCR3 and CCR2B share common polarity motif in the first extracellular loop with other human G-protein coupled receptors - Implications for HIV-1 coreceptor function
    Efremov, R
    Truong, MJ
    Darcissac, ECA
    Zeng, J
    Grau, O
    Vergoten, G
    Debard, C
    Capron, A
    Bahr, GM
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03): : 746 - 756
  • [47] Inhibition of HIV-1 infection by the beta-chemokine MDC
    Pal, R
    GarzinoDemo, A
    Markham, PD
    Burns, J
    Brown, M
    Gallo, RC
    DeVico, AL
    [J]. SCIENCE, 1997, 278 (5338) : 695 - 698
  • [48] The role of CCR5 and other chemokine receptors in HIV entry.
    Blanpain, C
    Libert, F
    Lee, B
    Vakili, J
    Migeotte, I
    Govaerts, C
    Maho, A
    Samson, M
    Doranz, B
    Rucker, J
    Detheux, M
    Vassart, G
    Doms, RW
    Parmentier, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U117 - U117
  • [49] Synthesis of peptides mimicking chemokine receptor CCR5 and their inhibitory effects against HIV-1 infection
    Konishi, K
    Ikeda, K
    Achiwa, K
    Hoshino, H
    Tanaka, K
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2000, 48 (02) : 308 - 309
  • [50] Phenotytic Knockout of HIV-1 Chemokine Coreceptor CXCR4 and CCR5 by Intrakines for Blocking HIV-1 Infection
    张颖
    张岩
    王平忠
    王九平
    黄长形
    孙永涛
    白雪帆
    [J]. Journal of Microbiology and Immunology, 2004, (04) : 255 - 259